Development of a dietary formulation of the SHetA2 chemoprevention drug for mice-Reference-Cited by-同舟云学术

Development of a dietary formulation of the SHetA2 chemoprevention drug for mice

Published:2017-12-22 Issue:4 Volume:36 Page:561-570
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Benbrook Doris M.^ORCID,Janakiram Naveena B.,Chandra Vishal,Pathuri Gopal,Madka Venkateshwar,Stratton Nicole C.,Masamha Chioniso P.,Farnsworth Cassadie N.,Garcia-Contreras Lucila,Hatipoglu Manolya Kukut,Lighfoot Stan,Rao Chinthalapally V.

Funder

National Cancer Institute

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/article/10.1007/s10637-017-0550-0/fulltext.html

Reference20 articles.

1. Viswanathan AN, Lee LJ, Eswara JR, Horowitz NS, Konstantinopoulos PA, Mirabeau-Beale KL, Rose BS, von Keudell AG, Wo JY (2014) Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer 120(24):3870–3883

2. Suh DH, Kim M, Kim HJ, Lee KH, Kim JW (2016) Major clinical research advances in gynecologic cancer in 2015. J Gynecol Oncol 27(6):e53

3. Waters EA, Cronin KA, Graubard BI, Han PK, Freedman AN (2010) Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women. Cancer Epidemiol Biomark Prev 19(2):443–446. https://doi.org/10.1158/1055-9965.epi-09-0930

4. Freedman AN, Yu B, Gail MH, Costantino JP, Graubard BI, Vogel VG, Anderson GL, McCaskill-Stevens W (2011) Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. J Clin Oncol 29(17):2327–2333. https://doi.org/10.1200/jco.2010.33.0258

5. Liu S, Brown CW, Berlin KD, Dhar A, Guruswamy S, Brown D, Gardner GJ, Birrer MJ, Benbrook DM (2004) Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells. J Med Chem 47(4):999–1007. https://doi.org/10.1021/jm030346v

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety Evaluation of Curcumol by a Repeated Dose 28-Day Oral Exposure Toxicity Study in Rats;Toxics;2023-01-24

2. Abrogating the Interaction Between p53 and Mortalin (Grp75/HSPA9/mtHsp70) for Cancer Therapy: The Story so far;Frontiers in Cell and Developmental Biology;2022-04-14

3. SHetA2 Attack on Mortalin and Colleagues in Cancer Therapy and Prevention;Frontiers in Cell and Developmental Biology;2022-02-23

4. Complementary Targeting of Rb Phosphorylation and Growth in Cervical Cancer Cell Cultures and a Xenograft Mouse Model by SHetA2 and Palbociclib;Cancers;2020-05-17

5. Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53;International Journal of Cancer;2020-01-08